Cap on Medicare Part D Drug Costs for Seniors
This act introduces an annual out-of-pocket spending cap for seniors enrolled in Medicare Part D, aiming to reduce their financial burden. Drug manufacturers will be required to offer discounts at the point of sale, with the program set to begin in 2022. These changes are intended to directly lower drug costs for many Medicare beneficiaries.
Key points
Implementation of an annual out-of-pocket spending limit for prescription drugs for seniors in Medicare Part D, effective from 2022.
Mandatory point-of-sale discounts from drug manufacturers to reduce immediate costs for patients.
Establishment of a new manufacturer discount program, replacing the existing Medicare coverage gap discount program.
Expired
Citizen Poll